The global artificial urinary sphincter market accounted for USD 0.533 billion in 2023 and is expected to reach USD 1.14 billion by 2034 with a CAGR of 7.17% during the forecast period 2024-2034. The rising prevalence of urinary incontinence (UI), a growing geriatric population, technological advancements in AUS, increased adoption of minimally invasive procedures, increased awareness and patient education, and rising strategic collaborations and partnerships will all fuel market expansion.
Urinary incontinence is a widespread medical problem that affects millions of individuals worldwide. Obesity, childbearing, prostate surgery, neurological problems, and aging all increase the risk of urine incontinence. As knowledge of this issue grows and detection rates improve, more people seek treatment options, increasing the market for prosthetic urinary sphincters. For instance, the National Center for Biotechnology Information (NCBI) report from January 2022 estimates that the expected prevalence of BPH varied from 23.79% in the Gulf cluster to 23.76% in Egypt to 13.84% in Turkey and Middle Eastern countries.
By product type, the multi-component AUS segment accounted for the highest revenue-grossing segment in the global artificial urinary sphincter market in 2023 owing to the increasing complexity of urinary control needs and advancements in medical technology enabling more sophisticated solutions for patients with urinary incontinence. For instance, Boston Scientific announced in January 2023 that it would acquire Farapulse, Inc., a privately held business that was creating a non-thermal ablation technology for the treatment of atrial fibrillation. Additionally, the single-component AUS segment is predicted to grow at the fastest CAGR during the forecast period owing to the rising demand for simpler and cost-effective solutions, particularly in regions with limited healthcare resources, and increasing adoption of single-component AUS devices in ambulatory surgical centers and outpatient settings.
By gender, the male segment accounted for the highest revenue-grossing segment in the global artificial urinary sphincter market in 2023 owing to the higher prevalence of urinary incontinence in men, particularly post-prostatectomy, and increasing awareness and acceptance of treatment options among male patients. For instance, in December 2023, Coloplast reported that it had completed the acquisition of Comfort Medical, a major supplier of urological equipment and catheter supplies, in a transaction estimated to be worth $2.2 billion. Additionally, the female segment is predicted to grow at the fastest CAGR during the forecast period owing to the growing recognition of urinary incontinence as a significant issue among women, advancements in female-specific AUS devices, and increasing emphasis on women's healthcare, driving greater adoption of artificial urinary sphincters among female patients.
By end-user, the hospital's segment accounted for the highest revenue-grossing segment in the global artificial urinary sphincter market in 2023 owing to the preference for hospitals among patients for complex surgeries, the availability of advanced medical facilities, and the expertise of specialized healthcare professionals in treating urinary incontinence. For instance, ZSI Surgical Implants announced in November 2023 the release of the ZSI 200, a new generation of artificial urinary sphincters with creative design enhancements for improved patient results. Additionally, the academic and research institutes segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing focus on research and development of advanced medical technologies, collaborations with industry partners for innovation, and the role of academic institutions in training healthcare professionals on the latest techniques and treatments for urinary incontinence, including artificial urinary sphincters.
North American region is anticipated to have the highest revenue share during the forecast period owing to the higher prevalence of urinary incontinence, greater healthcare expenditure, advanced healthcare infrastructure, and early adoption of novel medical technologies in the region. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the increasing awareness about urinary incontinence treatment options, rising healthcare expenditure, improving healthcare infrastructure, and a growing elderly population with higher susceptibility to urinary incontinence issues. For instance, RBM-Med said in September 2023 that it was expanding its distribution network into new areas to improve access to its assortment of urological products, which includes prosthetic urinary sphincters.
This extensive research report concentrates on the size and projections of the global and regional markets from 2023 to 2034.
Urinary incontinence is a widespread medical problem that affects millions of individuals worldwide. Obesity, childbearing, prostate surgery, neurological problems, and aging all increase the risk of urine incontinence. As knowledge of this issue grows and detection rates improve, more people seek treatment options, increasing the market for prosthetic urinary sphincters. For instance, the National Center for Biotechnology Information (NCBI) report from January 2022 estimates that the expected prevalence of BPH varied from 23.79% in the Gulf cluster to 23.76% in Egypt to 13.84% in Turkey and Middle Eastern countries.
By product type, the multi-component AUS segment accounted for the highest revenue-grossing segment in the global artificial urinary sphincter market in 2023 owing to the increasing complexity of urinary control needs and advancements in medical technology enabling more sophisticated solutions for patients with urinary incontinence. For instance, Boston Scientific announced in January 2023 that it would acquire Farapulse, Inc., a privately held business that was creating a non-thermal ablation technology for the treatment of atrial fibrillation. Additionally, the single-component AUS segment is predicted to grow at the fastest CAGR during the forecast period owing to the rising demand for simpler and cost-effective solutions, particularly in regions with limited healthcare resources, and increasing adoption of single-component AUS devices in ambulatory surgical centers and outpatient settings.
By gender, the male segment accounted for the highest revenue-grossing segment in the global artificial urinary sphincter market in 2023 owing to the higher prevalence of urinary incontinence in men, particularly post-prostatectomy, and increasing awareness and acceptance of treatment options among male patients. For instance, in December 2023, Coloplast reported that it had completed the acquisition of Comfort Medical, a major supplier of urological equipment and catheter supplies, in a transaction estimated to be worth $2.2 billion. Additionally, the female segment is predicted to grow at the fastest CAGR during the forecast period owing to the growing recognition of urinary incontinence as a significant issue among women, advancements in female-specific AUS devices, and increasing emphasis on women's healthcare, driving greater adoption of artificial urinary sphincters among female patients.
By end-user, the hospital's segment accounted for the highest revenue-grossing segment in the global artificial urinary sphincter market in 2023 owing to the preference for hospitals among patients for complex surgeries, the availability of advanced medical facilities, and the expertise of specialized healthcare professionals in treating urinary incontinence. For instance, ZSI Surgical Implants announced in November 2023 the release of the ZSI 200, a new generation of artificial urinary sphincters with creative design enhancements for improved patient results. Additionally, the academic and research institutes segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing focus on research and development of advanced medical technologies, collaborations with industry partners for innovation, and the role of academic institutions in training healthcare professionals on the latest techniques and treatments for urinary incontinence, including artificial urinary sphincters.
North American region is anticipated to have the highest revenue share during the forecast period owing to the higher prevalence of urinary incontinence, greater healthcare expenditure, advanced healthcare infrastructure, and early adoption of novel medical technologies in the region. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the increasing awareness about urinary incontinence treatment options, rising healthcare expenditure, improving healthcare infrastructure, and a growing elderly population with higher susceptibility to urinary incontinence issues. For instance, RBM-Med said in September 2023 that it was expanding its distribution network into new areas to improve access to its assortment of urological products, which includes prosthetic urinary sphincters.
This extensive research report concentrates on the size and projections of the global and regional markets from 2023 to 2034.
Report Scope:
- Base Year: 2023
- Forecast Period: 2024-2034
- Study Coverage
- Market Forecast by Product Type, Gender, and End-User
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of the Top 10+ Major Market Players
Segmentation: Artificial Urinary Sphincter Market Report 2023 - 2034
Artificial Urinary Sphincter Market Analysis & Forecast by Product Type 2023 - 2034 (Revenue USD Bn)
- Single-Component AUS
- Multi-Component AUS
Artificial Urinary Sphincter Market Analysis & Forecast by Gender 2023 - 2034 (Revenue USD Bn)
- Male
- Female
Artificial Urinary Sphincter Market Analysis & Forecast by End-User 2023 - 2034 (Revenue USD Bn)
- Hospitals
- Clinics
- Academic and Research Institutes
- Others
Artificial Urinary Sphincter Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Artificial Urinary Sphincter Market: Product Type Estimates & Trend Analysis
8. Artificial Urinary Sphincter Market: Gender Estimates & Trend Analysis
9. Artificial Urinary Sphincter Market: End-User Estimates & Trend Analysis
10. Regional Market Analysis
11. North America Artificial Urinary Sphincter Market
12. Europe Global Artificial Urinary Sphincter Market
13. Asia Pacific Global Artificial Urinary Sphincter Market
14. Latin America Global Artificial Urinary Sphincter Market
15. MEA Global Artificial Urinary Sphincter Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- Boston Scientific Corporation
- Coloplast A/S
- ZSI Surgical Implants
- RBM-Med
- GT Urological
- Promedon
- Silimed
- UroMed
- Urotech GmbH
- Zephyr Surgical Implants
- Rocket Medical plc
- Marland Minimally Invasive Inc.
- Medi-Globe Corporation
- Menfis BioTech
- ROCAMED.
